Get the Stockscreener App
0.00
100.00%
-11.25
After Hours:
11.25
11.25
+
Bannix Acquisition Corp stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Bannix Acquisition Corp is a blank check company.
See More
Previous Close:
$11.25
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$45.92M
Revenue:
-
Net Income/Loss:
$65,400
P/E Ratio:
0.00
EPS:
0.015
Net Cash Flow:
$-1.12M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$11.25
52-Week Range:
$0.00
$11.72
Bannix Acquisition Corp Stock (BNIX) Company Profile
Name
Bannix Acquisition Corp
Sector
Industry
Phone
(201) 712-9800
Address
300 TICE BLVD, WOODCLIFF LAKE
Bannix Acquisition Corp Stock (BNIX) Latest News
Long Term Trading Analysis for (BNIX) - Stock Traders Daily
(BNIX) Trading Advice - Stock Traders Daily
Arcology introduces Ethereum's first parallel execution rollup - The Manila Times
Bannix Acquisition Corp. Extends Merger Deadline to 2024 - TipRanks
Bannix Acquisition Corp. Announces Monthly Extension to Complete its Initial Business Combination - The Manila Times
(BNIX) Investment Report - Stock Traders Daily
BP share price weakness is presenting a golden opportunity for long-term investors - Yahoo Finance UK
(BNIX) Trading Signals - Stock Traders Daily
Canopy Growth Announces Results of Annual General Meeting - Yahoo Canada Finance
James E. Flynn Buys 70,000 Shares of Bicara Therapeutics Inc. (NASDAQ:BCAX) Stock - Defense World
BANX stock touches 52-week high at $20.8 amid robust growth - Investing.com Canada
Ra capital executives buy Bicara Therapeutics shares for $32.99m - Investing.com India
Positive Ascendis data threatens BioMarin's lead in achondroplasia - The Pharma Letter
Banzai International, Inc. (NASDAQ:BNZI) Sees Large Growth in Short Interest - Defense World
Ascendis Challenges BioMarin, But Market Response Seems Excessive (NASDAQ:BMRN) - Seeking Alpha
Ascendis trial data piles pressure on BioMarin - BioPharma Dive
Bicara Therapeutics closes $362m IPO in flurry of biotech listing activity - Pharmaceutical Technology
Bicara Therapeutics raises $362 million in Nasdaq debut - The Pharma Letter
BANPU Surges 6% Following NatGas Unit Launching IPO in NYSE - KAOHOON INTERNATIONAL
Bannix Acquisition Corp. Strives to Secure VisionWave Merger - TipRanks
U.S. Markets Finished Mixed Monday As Carvana Led, BioMarin Pharmaceutical Lagged - Barron's
Bicara Therapeutics Announces Closing of $362 Million - GlobeNewswire
Despite Being First Mover, BioMarin's Voxzogo For Dwarfism To Face Pressure From Ascendis' Candidate In Near Term - Yahoo Finance
BioMarin off 17% as Ascendis data seen as threat to Voxzogo - Seeking Alpha
Ascendis rises on positive trial data for dwarfism therapy - XM
Banzai International Inc’s latest rating changes from various analysts - Knox Daily
(BNIX) On The My Stocks Page - Stock Traders Daily
Bicara Therapeutics Opens at $26.25 , Upsized IPO Priced at $18 By Investing.com - Investing.com Canada
Bicara Therapeutics Rises 39% in Debut on Nasdaq - MarketWatch
Bicara, MBX Bio lead gainers among biotech IPOs (NASDAQ:BCAX) - Seeking Alpha
TPG-backed Bicara Therapeutics shares surge 46% in stellar market debut - MSN
Bicara Therapeutics Opens at $26.25 , Upsized IPO Priced at $18 - Investing.com India
TPG-backed Bicara Therapeutics raises $315 mln in US IPO - Reuters
Bannix Acquisition Corp. extends business combination deadline - Investing.com
Bannix Acquisition Corp. extends business combination deadline By Investing.com - Investing.com Australia
BNIX stock touches 52-week high at $11.2 amid market optimism - Investing.com Australia
(BNIX) Investment Analysis - Stock Traders Daily
Bannix Acquisition Corp. Extends Deadline for Business Deal - TipRanks
Stock Market Movers Today • Top Gainers & Losers - Benzinga
NatWest eyes loan risk transfers to spur new lending and protect dividends - Yahoo Finance UK
How the (BNIX) price action is used to our Advantage - Stock Traders Daily
Bannix Acquisition Corp. Extends Merger Deadline with Sponsor Support - TipRanks
Best Penny Stocks for Today (Charts Updated Daily) - Benzinga
Trending tickers: latest investor updates on Tesla, Nvidia, Pfizer and Superdry - Yahoo Finance UK
Bannix Acquisition Corp. Announces Monthly Extension To Complete Its Initial Business Combination To March 14, 2024 - Quantisnow
(BNIX) Proactive Strategies - Stock Traders Daily
Gas prices: British Columbia cities push national average higher - Yahoo Canada Finance
Bank of England set to hold interest rates despite inflation hitting 2% target - Yahoo Finance UK
When the Price of (BNIX) Talks, People Listen - Stock Traders Daily
Bannix Acquisition Corp. Extends Deadline for Strategic TransactionTipRanks.com - TipRanks
Bannix Acquisition Corp Stock (BNIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):